Challenges in achieving adequate glycemic control among children with type 1 diabetes mellitus in a resource-limited

Lena Ali1, Mohammed Alhassan2

  • 1Family Medicine Board, Sudan Medical Specialization Board, Khartoum, Sudan.

Insights

Glycemic control is poor in Sudanese children with type 1 diabetes mellitus (T1DM), especially adolescents. Factors like family structure and infrequent blood glucose monitoring impact outcomes, necessitating targeted interventions.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes mellitus (T1DM) is a chronic condition requiring lifelong management.
  • Effective glycemic control in children is crucial for preventing long-term complications.
  • Limited data exists on T1DM management in resource-limited settings like Sudan.

Purpose of the Study:

  • To evaluate glycemic control in pediatric T1DM patients in Wad-Madani City, Sudan.
  • To identify factors associated with glycemic control in this population.
  • To inform the development of targeted interventions for improved diabetes care.

Main Methods:

  • Cross-sectional observational study at a Sudanese referral center.
  • Included 211 children (aged 1-18 years) with T1DM diagnosed over a year prior.
  • Collected data on glycemic control, sociodemographic, and clinical characteristics.

Main Results:

  • Only 6.2% achieved adequate glycemic control; adolescents showed particularly poor control (97.8%).
  • Mean HbA1c was 10.4%. Poor control linked to older age, single-parent households, infrequent SMBG, and larger family size.
  • High rates of DKA (33.8%), lipodystrophy (34.1%), and arthropathy (25.1%) were observed.

Conclusions:

  • A very low percentage of children with T1DM achieved adequate glycemic control, with adolescents being a vulnerable group.
  • Self-monitoring of blood glucose frequency and family dynamics are key factors influencing control.
  • Urgent need for tailored interventions and enhanced diabetes education in resource-limited settings.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174